Giletti, Andrea <br/><br/>
Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.  [electronic resource] 

 -  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences  Nov 2017 
 - 480-485 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1879-0720 
<br/><br/><label>Standard No.: </label>10.1016/j.ejps.2017.09.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Female<br/>Genotype<br/>Humans<br/>Liver-Specific Organic Anion Transporter 1--genetics<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--adverse effects<br/>Methylenetetrahydrofolate Reductase (NADPH2)--genetics<br/>Middle Aged<br/>Polymorphism, Genetic<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Reduced Folate Carrier Protein--genetics<br/>Tetrahydrofolate Dehydrogenase--genetics<br/>Thymidylate Synthase--genetics<br/>Young Adult